pamidronate disodium for injection powder for solution
sandoz canada incorporated - pamidronate disodium - powder for solution - 90mg - pamidronate disodium 90mg - bone resorption inhibitors
pamidronate disodium 15mg/5ml solution for infusion vials
medac uk - pamidronate disodium - solution for infusion - 3mg/1ml
pamidronate disodium 30mg/10ml solution for infusion vials
medac uk - pamidronate disodium - solution for infusion - 3mg/1ml
pamidronate disodium 60mg/20ml solution for infusion vials
medac uk - pamidronate disodium - solution for infusion - 3mg/1ml
pamidronate disodium 90mg/30ml solution for infusion vials
medac uk - pamidronate disodium - solution for infusion - 3mg/1ml
pamidronate disodium 3mg/ml mg/ml concentrate for soln for inf
neomed technology ltd - pamidronate disodium - concentrate for soln for inf - 3mg/ml mg/ml
pamidronate disodium 9mg/ml mg/ml concentrate for soln for inf
neomed technology ltd - pamidronate disodium - concentrate for soln for inf - 9mg/ml mg/ml
hospira pamidronate disodium injection 60 mg/10 ml vial
hospira australia pty ltd - pamidronate disodium, quantity: 6 mg/ml - injection, concentrated - excipient ingredients: water for injections; sodium hydroxide; mannitol; phosphoric acid - hypercalcemia of malignancy, paget's disease of the bone, and osteolytic bone metastases of breast cancer and osteolytic lesions of multiple myeloma
hospira pamidronate disodium injection 30 mg/10 ml vial
hospira australia pty ltd - pamidronate disodium, quantity: 3 mg/ml - injection, concentrated - excipient ingredients: phosphoric acid; sodium hydroxide; water for injections; mannitol - hypercalcemia of malignancy, pagets disease, osteolytic bone metastases of breast cancer and ostelytic lesions of multiple myeloma.
hospira pamidronate disodium injection 90 mg/10 ml vial
hospira australia pty ltd - pamidronate disodium, quantity: 9 mg/ml - injection, concentrated - excipient ingredients: sodium hydroxide; phosphoric acid; water for injections; mannitol - hypercalcemia of malignancy, pagets disease, osteolytic bone matastases of breast cancer and osteolytic lesions of multiple myeloma